Citadel Advisors

Citadel Advisors’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Citadel Advisors’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell
2019 Q4	$30K	Buy
2019 Q3	$57K	Sell
2019 Q2	$207K	Buy
2019 Q1	$53K	Sell
2018 Q4	$60K	Buy
2018 Q3	$250K	Sell
2018 Q2	$469K	Buy
2018 Q1	$88K	Sell
2017 Q4	$296K	Buy